EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Molecular mechanisms of osteosarcoma metastasis and possible treatment opportunities

Xinhui Du, Hua Wei, Boya Zhang, Bangmin Wang, Zhehuang Li, Lon Kai Pang, Ruiying Zhao, Weitao Yao

Frontiers in Oncology · 01.05.2023 · 13

DOI: 10.3389/fonc.2023.1117867 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Oncology, online erschienen am 01.05.2023. Verfasst von Xinhui Du und 7 weiteren Autor:innen. Beteiligte Einrichtung: Bone Soft Tissue Department, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 103 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In osteosarcoma patients, metastasis of the primary cancer is the leading cause of death. At present, management options to prevent metastasis are limited and non-curative. In this study, we review the current state of knowledge on the molecular mechanisms of metastasis and discuss promising new therapies to combat osteosarcoma metastasis. Genomic and epigenomic changes, metabolic reprogramming, transcription factors, dysregulation of physiologic pathways, and alterations to the tumor microenvironment are some of the changes reportedly involved in the regulation of osteosarcoma metastasis. Key factors within the tumor microenvironment include infiltrating lymphocytes, macrophages, cancer-associated fibroblasts, platelets, and extracellular components such as vesicles, proteins, and other secreted molecules. We conclude by discussing potential osteosarcoma-limiting agents and their clinical studies.

Schlagwörter

Stichwörter der Autor:innen

mechanismmetastasisosteosarcomareprogrammingtumor microenvironment

Autor:innen und Institutionen

  • Bone Soft Tissue Department, The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, Zhengzhou, China.
  • Key Laboratory for Digital Assessment of Spinal-Pelvic Tumor and Surgical Aid Tools Design (Zhengzhou), Zhengzhou, Henan, China.
  • Key Laboratory for Perioperative Digital Assessment of Bone Tumors (Henan), Zhengzhou, Henan, China.
  • Department of Anesthesiology, Pain and Perioperative Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
  • Baylor College of Medicine, Houston, TX, United States.
  • Department of Integrative Biology and Pharmacology, McGovern Medical School, The University of Texas Health Science Center at Houston, Houston, TX, United States.

Zitieren

APA

Du, X., Wei, H., Zhang, B., Wang, B., Li, Z., Pang, L. K., Zhao, R., & Yao, W. (2023). Molecular mechanisms of osteosarcoma metastasis and possible treatment opportunities. Frontiers in Oncology, 13. https://doi.org/10.3389/fonc.2023.1117867

Vancouver

Du X, Wei H, Zhang B, Wang B, Li Z, Pang LK, et al. Molecular mechanisms of osteosarcoma metastasis and possible treatment opportunities. Frontiers in Oncology. 2023;13. doi:10.3389/fonc.2023.1117867

BibTeX
@article{Du2023,
  author = {Du, Xinhui and Wei, Hua and Zhang, Boya and Wang, Bangmin and Li, Zhehuang and Pang, Lon Kai and Zhao, Ruiying and Yao, Weitao},
  title = {Molecular mechanisms of osteosarcoma metastasis and possible treatment opportunities},
  journal = {Frontiers in Oncology},
  year = {2023},
  volume = {13},
  doi = {10.3389/fonc.2023.1117867}
}
Kostenlos starten →